GLP and GMP Method Development, Validation and Remediation

Good manufacturing practice is the piece of quality assurance which ensures that things are reliably made and controlled to the quality standard proper to their proposed use and as required by the Marketing Authorization or item particular. GMP is stressed over both generation and quality control, consistency with this standard gives open assurance that the rights, security, and prosperity of trial subjects are ensured; predictable with the rule that have their starting point in the Declaration of Helsinki, and that the clinical information is valid.

 

  • Guideline versions
  • High-Level Details
  • CGMP inspections
  • Enforcement
  • Controlled Environmental conditions

Related Conference of GLP and GMP Method Development, Validation and Remediation

November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

GLP and GMP Method Development, Validation and Remediation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in